Entity
  • TreeFrog Therapeutics

    Created in 2018
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    913 16,454
  • Global tags

  • Activities

  • Technologies

  • Entity types

  • Location

    30 Av. Gustave Eiffel Bat A, 33600 Pessac, France

    Pessac

    France

  • Employees

    Scale: 51-200

    Estimated: 137

  • SIREN

    343619102
  • Engaged corporates

    35
    13 26
  • Added in Motherbase

    4 years, 7 months ago
Description
  • Value proposition

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

    Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivation

  • Original language

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

  • TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All

    TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.

  • https://treefrog.fr/
Corporate interactions BETA
Corporate TypeTweets Articles
Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique
Government Administration
Other

12 Feb 2024


Aquitaine Science Transfert (SATT Aquitaine) Aquitaine Science Transfert (SATT Aquitaine)
Other

14 Mar 2024


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

14 Dec 2023


ALPHA-RLH, le pôle français des ondes de l'innovation
ALPHA-RLH, le pôle français des ondes de l'innovation
Research, Public business cluster, French Cluster, Research Services
ALPHA-RLH, le pôle français des ondes de l'innovation
Research, Public business cluster, French Cluster, Research Services
Other

4 Dec 2023


Gouvernement Gouvernement
Other

16 Jun 2023


Institut du Cerveau – Paris Brain Institute
Institut du Cerveau – Paris Brain Institute
Startup accelerator & VC, Biotechnology Research
Institut du Cerveau – Paris Brain Institute
Startup accelerator & VC, Biotechnology Research
Other

8 Mar 2023


Inria
Inria
Research, Research Services
Inria
Research, Research Services
Other

8 Mar 2023


French Tech Bordeaux
French Tech Bordeaux
French Tech, IT Services and IT Consulting
French Tech Bordeaux
French Tech, IT Services and IT Consulting
Not capitalistic
Not partnership
Event

2 Aug 2023


Moderna
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Not capitalistic
Partnership
Event

15 Nov 2021


BFM Business
BFM Business
Media, Broadcast Media Production and Distribution
BFM Business
Media, Broadcast Media Production and Distribution
Not capitalistic
Not partnership
Event

26 Apr 2024


Similar entities
Loading...
Loading...
Social network dynamics